These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35322585)

  • 1. Uptake of genetic counseling and testing in a clinic-based population of women with breast cancer.
    Wehbe A; Manning M; Assad H; Purrington KS; Simon MS
    Cancer Med; 2022 Sep; 11(17):3304-3311. PubMed ID: 35322585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.
    Sutton AL; Hurtado-de-Mendoza A; Quillin J; Rubinsak L; Temkin SM; Gal T; Sheppard VB
    J Womens Health (Larchmt); 2020 Aug; 29(8):1131-1135. PubMed ID: 31794334
    [No Abstract]   [Full Text] [Related]  

  • 3. Referral, Uptake, and Outcome of Genetic Counseling and Testing in Patients With Early-Onset Colorectal Cancer.
    Syed H; Sommovilla J; Burke CA; McGee S; Macaron C; Heald B; Lyu R; Schmit SL; Nair K; Kamath S; Krishnamurthi S; Khorana AA; Liska D
    J Natl Compr Canc Netw; 2023 Nov; 21(11):1156-1163.e5. PubMed ID: 37935108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Disparities in Breast Cancer Genetic Testing May be Mitigated by Counseling.
    Siegel JB; Bertolino M; Mukherjee R; Meeder K; Hughes KS; Abbott AM
    Ann Surg Oncol; 2024 Aug; 31(8):5197-5204. PubMed ID: 38811498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
    Stuckey A; Febbraro T; Laprise J; Wilbur JS; Lopes V; Robison K
    Am J Clin Oncol; 2016 Aug; 39(4):363-7. PubMed ID: 24710121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
    Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
    Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
    Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C
    Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
    Trivers KF; Baldwin LM; Miller JW; Matthews B; Andrilla CH; Lishner DM; Goff BA
    Cancer; 2011 Dec; 117(23):5334-43. PubMed ID: 21792861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider discussion of genetic counseling among high-risk Spanish-preferring Latina breast cancer survivors.
    Conley CC; Rivera Rivera JN; Castro-Figueroa EM; Moreno L; Dutil J; García JD; Ricker C; Quinn GP; Soliman H; Vadaparampil ST
    Transl Behav Med; 2022 Oct; 12(9):900-908. PubMed ID: 36205471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.
    Wood ME; Kadlubek P; Pham TH; Wollins DS; Lu KH; Weitzel JN; Neuss MN; Hughes KS
    J Clin Oncol; 2014 Mar; 32(8):824-9. PubMed ID: 24493722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
    Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A
    Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
    Hoskins KF; Tejeda S; Vijayasiri G; Chukwudozie IB; Remo MH; Shah HA; Abraham IE; Balay LE; Maga TK; Searles ER; Korah VJ; Biggers A; Stolley MR; Warnecke RB
    Cancer; 2018 Sep; 124(18):3733-3741. PubMed ID: 30320429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
    Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
    J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial.
    Pasick RJ; Joseph G; Stewart S; Kaplan C; Lee R; Luce J; Davis S; Marquez T; Nguyen T; Guerra C
    Am J Public Health; 2016 Oct; 106(10):1842-8. PubMed ID: 27552275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in breast cancer hereditary risk assessment referrals.
    Peterson JM; Pepin A; Thomas R; Biagi T; Stark E; Sparks AD; Johnson K; Kaltman R
    J Genet Couns; 2020 Aug; 29(4):587-593. PubMed ID: 32196827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer Patients.
    Choi JJ; Fikre T; Fischman A; Buck AK; Ko NY
    Oncologist; 2022 Oct; 27(10):832-838. PubMed ID: 36124631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in genetics assessment for women with ovarian cancer: Can we do better?
    Manrriquez E; Chapman JS; Mak J; Blanco AM; Chen LM
    Gynecol Oncol; 2018 Apr; 149(1):84-88. PubMed ID: 29605055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system.
    Powell CB; Laurent C; Garcia C; Hoodfar E; Karlea A; Kobelka C; Lee J; Roh J; Kushi LH
    Clin Genet; 2022 Mar; 101(3):324-334. PubMed ID: 34927729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Implementing B-RST
    Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
    Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.